Scholars@Duke

Postapproval drug safety: The authors respond [8]

Publication ,  Journal Article
Ridley, DB; Kramer, JM
Published in: Health Affairs
January 1, 2006
Published version (DOI)

Duke Scholars

David Blaine Ridley
Author David Blaine Ridley Fuqua School of Business
Judith Mae Kramer
Author Judith Mae Kramer Medicine, General Internal Medicine

Published In

Health Affairs

DOI

10.1377/hlthaff.25.4.1184-a

EISSN

0278-2715

ISSN

0278-2715

Publication Date

January 1, 2006

Volume

25

Issue

4

Start / End Page

1187 / 1188

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ridley, D. B., & Kramer, J. M. (2006). Postapproval drug safety: The authors respond [8]. Health Affairs, 25(4), 1187–1188. https://doi.org/10.1377/hlthaff.25.4.1184-a
Ridley, D. B., and J. M. Kramer. “Postapproval drug safety: The authors respond [8].” Health Affairs 25, no. 4 (January 1, 2006): 1187–88. https://doi.org/10.1377/hlthaff.25.4.1184-a.
Ridley DB, Kramer JM. Postapproval drug safety: The authors respond [8]. Health Affairs. 2006 Jan 1;25(4):1187–8.
Ridley, D. B., and J. M. Kramer. “Postapproval drug safety: The authors respond [8].” Health Affairs, vol. 25, no. 4, Jan. 2006, pp. 1187–88. Scopus, doi:10.1377/hlthaff.25.4.1184-a.
Ridley DB, Kramer JM. Postapproval drug safety: The authors respond [8]. Health Affairs. 2006 Jan 1;25(4):1187–1188.

Published In

Health Affairs

DOI

10.1377/hlthaff.25.4.1184-a

EISSN

0278-2715

ISSN

0278-2715

Publication Date

January 1, 2006

Volume

25

Issue

4

Start / End Page

1187 / 1188

Related Subject Headings

  • Health Policy & Services
  • 4407 Policy and administration
  • 4203 Health services and systems
  • 1402 Applied Economics
  • 1117 Public Health and Health Services